-
In vivo staging of pathology in REM sleep behaviour disorder
-
Incidence of Parkinson’s disease: Pooled analysis of six high-quality incidence studies with long-term follow-up
-
Incidence, prevalence and clinical features of sleep disorders in alphasynucleinopthies: A cohort study
-
Incobotulinum toxin type A for the treatment of biceps/triceps co-contraction due to obstetrical brachial plexus lesion
-
Increased Parkin expression in a PARK20 (SYNJ1 mutation) iPSCs-based model
-
Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
-
Incremental hourly burden of “OFF” episodes on patient quality of life and health resource use among patients with Parkinson’s disease: A Neurologist/Patient Real World Assessment in the US
-
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry
-
Influence of baseline OFF-time in the efficacy response of opicapone in Parkinson’s disease patients with motor fluctuations: The BIPARK-I double-blind experience
-
Influence of disease progression on the quality of life of individuals with spinocerebellar ataxia type 10
- « Previous Page
- 1
- …
- 85
- 86
- 87
- 88
- 89
- …
- 177
- Next Page »